Previous Close | 24.30 |
Open | 24.90 |
Bid | 20.70 |
Ask | 24.00 |
Strike | 200.00 |
Expire Date | 2024-07-19 |
Day's Range | 24.30 - 24.90 |
Contract Range | N/A |
Volume | |
Open Interest | 190 |
Haemonetics' (HAE) hospital portfolio is evolving and helping to create new opportunities for growth and diversification.
Per Maravai LifeSciences (MRVI) management, this development by TriLink is set to advance nucleic acid-based therapies.
Investors are optimistic about Haemonetics (HAE) led by its strategic focus on establishing leading positions in high-growth markets to generate solid financial returns.